GLOBAL BIOSIMILARS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

May 2019 119

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Scope of the Report:
The worldwide market for Biosimilars is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Sandoz International
- Hospira
- Teva Pharmaceutical
- Dr. Reddy’s Laboratories
- Biocon
- Mylan
- Amgen
- Celltrion
- Roche Diagnostics
- Merck KGaA

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Type I
- Type II

Market Segment by Applications, can be divided into
- Application I
- Application II

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Biosimilars product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Biosimilars, with price, sales, revenue and global market share of Biosimilars in 2017 and 2018.
Chapter 3, the Biosimilars competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Biosimilars breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Biosimilars sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Table of Contents

Related reports :

(Jan 24)

According to our (Global Info Research) latest study, the global Deferiprone market size was valued at USD 37 million in 2023 and is forecas...

(Jan 24)

According to our (Global Info Research) latest study, the global Deferasirox market size was valued at USD 2808.8 million in 2023 and is for...

(Jan 24)

According to our (Global Info Research) latest study, the global Biopharmaceutical Logistic market size was valued at USD 88220 million in 2...

(Jan 24)

According to our (Global Info Research) latest study, the global Legal Marijuana market size was valued at USD 28400 million in 2023 and is ...

(Jan 24)

According to our (Global Info Research) latest study, the global Vaccine Adjuvants market size was valued at USD 877.5 million in 2023 and i...

(Jan 24)

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 an...

GLOBAL BIOSIMILARS MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Global Info Research

Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy